NOVEL 2H-INDAZOLES AS EP2 RECEPTOR ANTAGONISTS EP2 2H

The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2-receptor.

Saved in:
Bibliographic Details
Main Authors BRAEUER, NICO N, ROTGERI, ANDREA A, TER LAAK, ANTONIUS A, BUCHMANN, BERND B, ROEHN, ULRIKE U, LINDENTHAL, BERNHARD B, MENGEL, ANNE A
Format Patent
LanguageChinese
English
Published 06.11.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2-receptor.
Bibliography:Application Number: HK20150104364